医疗设备射出成型机市场：依机器类型、材料类型、扣夹力和应用划分，全球预测（2026-2032年）

预计到 2025 年，医疗设备射出成型机市场价值将达到 6.5484 亿美元，到 2026 年将成长至 7.0614 亿美元，到 2032 年将达到 10.2037 亿美元，复合年增长率为 6.54%。

关键市场统计数据
基准年 2025	6.5484亿美元
预计年份：2026年	7.0614亿美元
预测年份 2032	1,020,370,000 美元
复合年增长率 (%)	6.54%

针对医疗设备射出成型机市场趋势的全面指导，重点在于技术选择、监管挑战和采购重点。

医疗设备射出成型产业处于精密製造、严格法律规范以及对用于植入、器械和一次性产品的聚合物基组件日益增长的需求三者交汇的阶段。材料科学的进步、日益严格的临床规范以及对自动化需求的不断增长，正推动着对设备性能、重复性和可追溯性的要求不断提高。随着製造商力求提高营运效率和产量比率，机器可靠性、製程控制以及与数位化品质系统的整合已成为关键的采购标准。

自动化、材料创新和监管要求如何共同作用，重新定义注塑设备的采购标准和营运预期

受技术、监管和营运因素的影响，医疗设备射出成型机的市场环境正在经历变革性变化。自动化和工业4.0整合已不再是可选项，而是确保合规性和可追溯性的基础生产技术。封闭回路型过程控制、在线连续检测以及机器与製造执行系统（MES）的连接在降低变异性和应对监管审查方面发挥核心作用。同时，伺服驱动系统和混合配置的进步正在重新定义週期时间和能源效率的预期，并改变企业生命週期内总拥有成本（TCO）的计算方式。

贸易政策的变化迫使企业重新调整筹资策略和供应商选择，同时优化生命週期成本以降低关税风险。

2025年的关税趋势和不断变化的贸易政策给射出成型设备行业的製造商和资本支出负责人带来了新的挑战。关税表的变化对精密机械和关键子系统的进口成本产生了相对影响，进而影响了筹资策略、供应商选择和总到岸成本的计算。采购团队不得不重新审视其供应商组合，并重新评估国内采购、近岸外包和传统进口管道之间的权衡取舍。

将机器架构、材料相容性、夹紧力范围和应用需求与采购和检验策略连结起来的详细細項分析

細項分析揭示了机器架构、材料相容性、夹紧力要求和最终用途等明确的决策驱动因素，这些因素分别指导采购和製程设计。根据机器类型，市场可分为全电动、混合动力和液压三种类型。每种架构各有优势：全电动系统通常因其精度、重复性和能源效率而备受青睐，而混合动力平台则在中高负载环境下实现了力和速度的平衡。液压机械在高吨位、高压应用中保持主导地位，在这些应用中，纯粹的力是关键参数。

区域管理体制、供应链生态系统和服务网络如何推动全球差异化的设施策略和製造地选址

区域趋势持续以显着不同的方式影响美洲、欧洲、中东和非洲以及亚太地区的製造地、供应商生态系统和服务网络。在美洲，製造商通常优先考虑与本地供应商建立关係、提供快速回应的售后支援以及遵守关键监管机构的规定，从而推动对模组化生产线和本地服务能力的投资。同时，在欧洲、中东和非洲，对严格监管协调、永续性要求和能源效率目标的共同关注，推动了先进控制系统和闭合迴路品质监控技术的应用。

供应商格局分析：重点阐述OEM创新、专业知识和不断发展的服务将如何重塑采购标准和伙伴关係模式

射出成型设备产业的企业层面趋势显示，全球原始设备製造商 (OEM)、专业细分领域供应商和垂直整合供应商共同构成了一个多元化的市场，为医疗设备製造商提供专业解决方案。主要企业正大力投资数位化，提供涵盖製程控制、统计製程控制 (SPC) 分析和製造执行系统 (MES)互通性的整合软体套件，以支援端到端的可追溯性和快速验证週期。同时，专业供应商则专注于特定领域，例如用于植入的微成型、弹性体复合技术或针对厚壁零件优化的高吨位压平机，为具有特定技术需求的製造商提供宝贵的选择。

在采购、营运和供应商管治采取切实可行的优先行动，以缩短检验时间、提高韧性并优化全生命週期成果。

为保持竞争力并确保合规性，产业领导者应在采购、营运和供应商协作方面采取重点突出的执行策略。首先，将数位化应对力作为采购文件中的关键规范，确保机器支援安全的资料收集、与企业系统的整合以及用于流程最佳化的高阶分析。其次，优先采用模组化机器设计，允许逐步扩展产能和升级零件，而无需更换整个系统，从而降低资本投入并缩短检验週期。

我们采用透明且可复製的调查方法，结合一手访谈、技术检验和工程绩效指标，以确保实际相关性。

本研究整合了访谈资料、行业文献、技术白皮书和检验的工程信息，旨在深入了解设备性能、采购驱动因素和运营限制。访谈资料包括对製造工程师、品质主管、采购经理和售后服务专业人员的结构化访谈，以了解实际决策标准、挑战和所需的机器功能。二级资讯来源包括製造商技术规格、监管指导文件和同行评审的工程研究，以检验性能特征和技术发展趋势。

整合策略需求：机器选择、检验严谨性和供应商策略如何共同决定製造的韧性和竞争力

总之，目前医疗设备射出成型设备的现况需要一种兼顾技术能力、法规遵循和供应链韧性的策略方法。机器架构、材料相容性、夹紧力力以及应用需求构成了驱动采购和营运规划的核心决策矩阵。数位控制、自动化和材料科学的进步正在重新定义采购方应优先考虑的属性，而贸易政策和区域趋势则带来了影响采购和生命週期成本的实际考虑。

目录

第一章：序言

第二章调查方法

• 研究设计
• 研究框架
• 市场规模预测
• 数据三角测量
• 调查结果
• 调查前提
• 调查限制

第三章执行摘要

• 首席体验长观点
• 市场规模和成长趋势
• 2025年市占率分析
• FPNV定位矩阵，2025
• 新的商机
• 下一代经营模式
• 产业蓝图

第四章 市场概览

• 产业生态系与价值链分析
• 波特五力分析
• PESTEL 分析
• 市场展望
• 上市策略

第五章 市场洞察

• 消费者洞察与终端用户观点
• 消费者体验基准
• 机会地图
• 分销通路分析
• 价格趋势分析
• 监理合规和标准框架
• ESG与永续性分析
• 中断和风险情景
• 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章医疗设备射出成型机市场（按类型划分）

• 全电动
• 杂交种
• 油压

第九章医疗设备射出成型机市场（依材料类型划分）

• 弹性体
• 热塑性树脂
• 热固性树脂

第十章夹紧力分類的医疗设备射出成型机市场

• 500至1000吨
• 超过1000吨
• 不到500吨

第十一章医疗设备射出成型机市场（依应用领域划分）

• 植入
• 手术器械
• 注射器

第十二章医疗设备射出成型机市场（按地区划分）

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十三章医疗设备射出成型机市场（依组别划分）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十四章 各国医疗设备射出成型机市场

• 我们
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十五章：美国医疗设备射出成型机市场

第十六章 中国医疗设备射出成型机市场

第十七章 竞争格局

• 市场集中度分析，2025年
  • 浓度比（CR）
  • 赫芬达尔-赫希曼指数 (HHI)
• 近期趋势及影响分析，2025 年
• 2025年产品系列分析
• 基准分析，2025 年
• ARBURG GmbH+Co KG
• Battenfeld-Cincinnati Austria GmbH
• BOY Machines, Inc.
• Chen Hsong Holdings Limited
• ENGEL Austria GmbH
• FANUC Corporation
• Haitian International Holdings Limited
• Husky Injection Molding Systems Ltd.
• JSW Plastics Machinery Inc.
• KraussMaffei Group GmbH
• LS Mtron Ltd.
• Milacron Holdings Corp.
• Negri Bossi SpA
• Niigata Machine Techno Co., Ltd.
• Nissei Plastic Industrial Co., Ltd.
• Plastiblow Srl
• Powerjet Plastic Machinery Co., Ltd.
• Shibaura Machine Co., Ltd.
• Sodick Co., Ltd.
• Sumitomo Heavy Industries, Ltd.
• Tederic Machinery Co., Ltd.
• Toshiba Machine Co., Ltd.
• Ube Machinery Corporation, Ltd.
• Wittmann Battenfeld GmbH
• Yizumi Precision Machinery Co., Ltd.

The Medical Device Injection Molding Machine Market was valued at USD 654.84 million in 2025 and is projected to grow to USD 706.14 million in 2026, with a CAGR of 6.54%, reaching USD 1,020.37 million by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 654.84 million
Estimated Year [2026]	USD 706.14 million
Forecast Year [2032]	USD 1,020.37 million
CAGR (%)	6.54%

Comprehensive orientation to the medical device injection molding machine landscape, highlighting technology choices, regulatory intersections, and procurement priorities

The medical device injection molding machine sector sits at the intersection of precision manufacturing, stringent regulatory oversight, and accelerating demand for polymer-based components used across implants, instruments, and disposables. Advances in materials science, tighter clinical specifications, and increasing automation imperatives have raised the bar for equipment performance, repeatability, and traceability. As manufacturers pursue leaner operations and higher yields, machine reliability, process control, and integration with digital quality systems have become primary purchasing criteria.

This report provides an evidence-based orientation for leaders who must reconcile capital intensity with the need for agility in producing mission-critical components. It frames the core technology choices that shape production outcomes-machine architecture, material compatibility, and clamping force ranges-while situating these within regulatory and supply chain realities. Readers will find a narrative that links engineering options to operational outcomes, so capital planners, quality leads, and R&D teams can prioritize investments that reduce scrap, shorten validation cycles, and enhance throughput.

Understanding this context is crucial for decision-makers seeking to align equipment acquisition with broader clinical and commercial goals, including speed to market, consistent product quality, and cost-effective manufacturing at scale.

How automation, materials innovation, and regulatory demands are jointly redefining procurement criteria and operational expectations for molding equipment

The landscape for medical device injection molding machines is undergoing transformative shifts driven by technological, regulatory, and operational forces. Automation and Industry 4.0 integrations have moved beyond optional upgrades to become enablers of compliant, traceable production; closed-loop process controls, inline inspection, and machine-to-MES connectivity are now central to reducing variability and satisfying regulatory scrutiny. Concurrently, advances in servo-driven systems and hybrid configurations have redefined expectations for cycle times and energy efficiency, altering total cost of ownership calculations across procurement horizons.

Material innovation has also reshaped machine requirements. Emerging thermoplastic and elastomer formulations demand precise thermal and shear control, pressing manufacturers to adopt machines with finer injection profiling and faster tool-change capabilities. Regulatory expectations for serialization, lot traceability, and implantable device validation have further prioritized machines that support extensive data capture and secure retention of process records.

Supply chain resilience concerns have prompted regionalization strategies, encouraging manufacturers to prioritize equipment that supports modular lines and rapid qualification. As a result, procurement decisions increasingly weigh operational flexibility, digital readiness, and validation support just as heavily as traditional metrics such as throughput and energy consumption. This confluence of trends is driving a new generation of procurement criteria that tie capital investment directly to compliance, speed, and adaptability.

Trade policy changes are reshaping sourcing strategies and supplier selection while forcing lifecycle cost optimization to mitigate tariff exposure risks

Tariff dynamics and trade policy shifts in 2025 introduced a new layer of complexity for manufacturers and capital planners in the injection molding equipment space. Changes to tariff schedules have affected the relative cost of importing precision machinery and critical subsystems, which has in turn influenced sourcing strategies, supplier selection, and total landed cost calculations. Procurement teams have had to revisit their supplier portfolios and reassess the trade-offs between domestic sourcing, nearshoring, and traditional import channels.

These tariff-related pressures have accelerated conversations around supplier diversification and vendor partnerships that can provide onshore assembly, local service networks, and expedited spare parts provisioning. Capital planning cycles now incorporate scenario analyses that account for tariff variability and potential supply interruptions. Engineering teams are prioritizing equipment that minimizes dependency on single-origin subsystems and that offers modularity to facilitate upgrades without full-system replacement.

Moreover, tariff-induced cost pressures have increased the emphasis on lifecycle cost optimization: energy efficiency, predictive maintenance capabilities, and tooling standardization are being evaluated not just for operational benefits but as mitigants to trade-policy exposure. In short, the tariff environment has prompted a strategic reorientation toward more resilient sourcing models and equipment choices that reduce exposure to cross-border cost volatility.

In-depth segmentation mapping that links machine architecture, material compatibility, clamping force ranges, and application demands to procurement and validation strategies

Segmentation analysis reveals distinct decision levers across machine architecture, material compatibility, clamping force requirements, and end-use applications, each of which informs procurement and process design pathways. Based on Machine Type, market is studied across All Electric, Hybrid, and Hydraulic. Each architecture brings differentiated strengths: all-electric systems are often favored for precision, repeatability, and energy efficiency; hybrid platforms balance force and speed for medium-to-high demand contexts; hydraulic machines retain advantages for high-tonnage, high-pressure applications where raw force is a critical parameter.

Based on Material Type, market is studied across Elastomer, Thermoplastic, and Thermoset. Material selection drives machine thermal management, screw/channel design, and mold-release strategies; elastomers require specialized handling to control cure and post-process distortion, while thermoplastics demand tight melt-temperature control and rapid cycle profiling. Thermosets introduce unique curing and demolding considerations that influence cycle planning and tooling investment.

Based on Clamping Force, market is studied across 500 To 1000 Tons, Above 1000 Tons, and Less Than 500 Tons. Clamping force categories map directly to component geometry, cavity count, and wall thickness requirements; lower-tonnage machines afford high-cavity, thin-walled consumer-type components, whereas higher-tonnage equipment supports larger implants, multi-drop tools, and deep-draw geometries. Based on Application, market is studied across Implants, Surgical Instruments, and Syringes. Application-driven constraints determine cleanliness regimes, material traceability needs, and validation intensity; implants require the most stringent validation and surface-finish control, surgical instruments prioritize dimensional stability and sterilization compatibility, and syringes emphasize cycle consistency and contamination control.

Taken together, these segmentation dimensions create a matrix that informs machine selection, line architecture, and validation planning. Procurement leaders should align machine capabilities with the dominant material and clamping force demands of targeted applications to ensure process capability and regulatory compliance.

How regional regulatory regimes, supply ecosystems, and service networks are driving differentiated equipment strategies and manufacturing footprints globally

Regional dynamics continue to shape manufacturing footprints, supplier ecosystems, and service networks in materially different ways across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, manufacturers often prioritize localized supplier relationships, rapid aftermarket support, and compliance pathways aligned with dominant regulatory authorities; these factors encourage investments in modular lines and onshore service capabilities. Conversely, Europe, Middle East & Africa typically emphasize stringent regulatory harmonization, sustainability mandates, and energy efficiency targets, driving uptake of advanced control systems and closed-loop quality monitoring.

Asia-Pacific remains a critical hub for component manufacturing and increasingly for higher-value equipment assembly. Its dense supplier networks and expanding capital equipment vendors provide competitive options for cost-sensitive production, though buyers must weigh variances in service coverage and qualification support. Regional labor costs, freight dynamics, and regulatory nuances combine to influence total cost of ownership, making geography a central concern for capital planning.

Given these differences, manufacturers adopt a hybrid approach that balances local responsiveness with the technical strengths of global suppliers. Equipment choices and aftermarket strategies are therefore tailored to the region's regulatory, logistical, and labor environment to optimize uptime, validation velocity, and operational resilience across distributed production sites.

Vendor landscape analysis highlighting how OEM innovation, specialist capabilities, and service evolution are reshaping procurement criteria and partnership models

Company-level dynamics in the injection molding equipment space reveal a landscape characterized by a mix of global OEMs, niche specialists, and vertically integrated suppliers that offer tailored solutions for medical device manufacturers. Leading equipment producers are investing heavily in digitalization, offering integrated software suites that span process control, SPC analytics, and MES interoperability to support end-to-end traceability and faster validation cycles. Meanwhile, specialist vendors focus on niche capabilities-such as implant-focused micro-molding, elastomer compounding expertise, or high-tonnage presses optimized for thick-walled components-providing valuable options for manufacturers with specific technical requirements.

Service models have evolved from reactive maintenance to subscription-like offerings that include predictive analytics, remote diagnostics, and prioritized spare parts provisioning. This shift reduces downtime risk and shortens qualification windows by enabling remote troubleshooting during validation runs. Partnerships between equipment suppliers and tooling houses have become more common, streamlining co-development of molds and machine configurations that minimize cycle time and scrap.

For procurement teams, vendor selection increasingly hinges on the availability of robust validation support, local service coverage, and a clear roadmap for software upgrades and cybersecurity provisioning. Companies that can combine machine performance with a suite of services that accelerates time-to-qualification will command a competitive advantage among medical device manufacturers.

Practical, prioritized actions for procurement, operations, and supplier governance that reduce validation time, improve resilience, and optimize total lifecycle outcomes

To maintain competitiveness and ensure compliance, industry leaders should adopt a set of focused, actionable priorities that span procurement, operations, and supplier collaboration. First, incorporate digital readiness as a primary specification in procurement documents so that machines support secure data capture, integration with enterprise systems, and advanced analytics for process optimization. Second, prioritize modular machine designs that allow incremental capacity expansion and component upgrades without full-system replacement, thereby reducing capital intensity and shortening validation cycles.

Third, strengthen supplier governance by mandating service-level agreements that include rapid spare parts delivery, on-site validation assistance, and remote diagnostic access. This approach mitigates downtime risk and accelerates qualification. Fourth, align material selection strategies with machine capabilities early in product development to minimize post-qualification adjustments and to ensure consistent clinical performance. Fifth, develop a cross-functional validation playbook that defines standard protocols for installation, operational, and performance qualification, enabling repeatable and auditable qualification across sites.

Finally, invest in workforce competencies around process monitoring, statistical process control, and digital maintenance tools to extract full value from advanced equipment. These actions collectively reduce operational friction, improve process capability, and position manufacturers to respond rapidly to regulatory shifts and market demand changes.

Transparent, reproducible research methodology combining primary interviews, technical verification, and engineering performance metrics to ensure practical relevance

This study synthesizes primary interviews, secondary industry literature, technical white papers, and validated engineering inputs to construct a robust understanding of equipment performance, procurement drivers, and operational constraints. Primary research included structured interviews with manufacturing engineers, quality leads, procurement managers, and aftermarket service professionals to capture real-world decision criteria, pain points, and desired machine features. Secondary sources comprised manufacturer technical specifications, regulatory guidance documents, and peer-reviewed engineering research to verify performance characteristics and technology trends.

Data triangulation was applied to reconcile divergent inputs and to ensure the analytical narrative reflects both practitioner experience and documented engineering performance. The methodology prioritized reproducibility by documenting interview protocols, key assumptions, and criteria for technology categorization. Comparative analysis across machine architectures, materials, clamping force categories, and applications was conducted using engineering performance indicators such as cycle stability, thermal control precision, and cleanroom compatibility.

Limitations were acknowledged where proprietary performance metrics or recent tariff adjustments introduced uncertainty; where possible, sensitivity analyses were used to illustrate how equipment selection trade-offs change under different operational constraints. The resulting methodology emphasizes transparency, practitioner relevance, and technical rigor to support confident decision-making by equipment buyers and operations leaders.

Synthesis of strategic imperatives showing how machine choices, validation rigor, and supplier strategies converge to determine manufacturing resilience and competitiveness

In conclusion, the medical device injection molding equipment landscape demands a strategic approach that balances technological capability, regulatory compliance, and supply chain resilience. Machine architecture, material compatibility, clamping force capacity, and application requirements form the core decision matrix that drives procurement and operational planning. Advances in digital controls, automation, and materials science are reshaping the attributes buyers must prioritize, while trade policy and regional dynamics introduce practical considerations that affect sourcing and lifecycle costs.

Manufacturers that align equipment selection with rigorous validation playbooks, strong supplier partnerships, and modular system designs will be best positioned to reduce time-to-market and maintain consistent clinical-grade output. Investments in digital readiness and predictive service models deliver tangible operational benefits, including reduced downtime and faster qualification. Ultimately, the ability to translate machine capabilities into validated, repeatable processes is the defining factor that determines manufacturing resilience and competitive advantage.

Leaders should therefore approach equipment decisions not as discrete purchases but as strategic enablers that require coordinated planning across engineering, quality, and procurement to realize sustained operational improvements.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Device Injection Molding Machine Market, by Machine Type

• 8.1. All Electric
• 8.2. Hybrid
• 8.3. Hydraulic

9. Medical Device Injection Molding Machine Market, by Material Type

• 9.1. Elastomer
• 9.2. Thermoplastic
• 9.3. Thermoset

10. Medical Device Injection Molding Machine Market, by Clamping Force

• 10.1. 500 To 1000 Tons
• 10.2. Above 1000 Tons
• 10.3. Less Than 500 Tons

11. Medical Device Injection Molding Machine Market, by Application

• 11.1. Implants
• 11.2. Surgical Instruments
• 11.3. Syringes

12. Medical Device Injection Molding Machine Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Medical Device Injection Molding Machine Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Medical Device Injection Molding Machine Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. United States Medical Device Injection Molding Machine Market

16. China Medical Device Injection Molding Machine Market

17. Competitive Landscape

• 17.1. Market Concentration Analysis, 2025
  • 17.1.1. Concentration Ratio (CR)
  • 17.1.2. Herfindahl Hirschman Index (HHI)
• 17.2. Recent Developments & Impact Analysis, 2025
• 17.3. Product Portfolio Analysis, 2025
• 17.4. Benchmarking Analysis, 2025
• 17.5. ARBURG GmbH + Co KG
• 17.6. Battenfeld-Cincinnati Austria GmbH
• 17.7. BOY Machines, Inc.
• 17.8. Chen Hsong Holdings Limited
• 17.9. ENGEL Austria GmbH
• 17.10. FANUC Corporation
• 17.11. Haitian International Holdings Limited
• 17.12. Husky Injection Molding Systems Ltd.
• 17.13. JSW Plastics Machinery Inc.
• 17.14. KraussMaffei Group GmbH
• 17.15. LS Mtron Ltd.
• 17.16. Milacron Holdings Corp.
• 17.17. Negri Bossi S.p.A.
• 17.18. Niigata Machine Techno Co., Ltd.
• 17.19. Nissei Plastic Industrial Co., Ltd.
• 17.20. Plastiblow Srl
• 17.21. Powerjet Plastic Machinery Co., Ltd.
• 17.22. Shibaura Machine Co., Ltd.
• 17.23. Sodick Co., Ltd.
• 17.24. Sumitomo Heavy Industries, Ltd.
• 17.25. Tederic Machinery Co., Ltd.
• 17.26. Toshiba Machine Co., Ltd.
• 17.27. Ube Machinery Corporation, Ltd.
• 17.28. Wittmann Battenfeld GmbH
• 17.29. Yizumi Precision Machinery Co., Ltd.

LIST OF FIGURES

• FIGURE 1. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 3. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 4. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 5. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 7. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 9. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 11. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 12. CHINA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY ALL ELECTRIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY ALL ELECTRIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY ALL ELECTRIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY HYBRID, BY REGION, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY HYBRID, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY HYBRID, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY HYDRAULIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY HYDRAULIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY HYDRAULIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY ELASTOMER, BY REGION, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY ELASTOMER, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY ELASTOMER, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY THERMOPLASTIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY THERMOPLASTIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY THERMOPLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY THERMOSET, BY REGION, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY THERMOSET, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY THERMOSET, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY 500 TO 1000 TONS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY 500 TO 1000 TONS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY 500 TO 1000 TONS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY ABOVE 1000 TONS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY ABOVE 1000 TONS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY ABOVE 1000 TONS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY LESS THAN 500 TONS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY LESS THAN 500 TONS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY LESS THAN 500 TONS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY SYRINGES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 42. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 43. AMERICAS MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 44. AMERICAS MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
• TABLE 45. AMERICAS MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 46. AMERICAS MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
• TABLE 47. AMERICAS MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 48. NORTH AMERICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 49. NORTH AMERICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
• TABLE 50. NORTH AMERICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 51. NORTH AMERICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
• TABLE 52. NORTH AMERICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 53. LATIN AMERICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 54. LATIN AMERICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
• TABLE 55. LATIN AMERICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 56. LATIN AMERICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
• TABLE 57. LATIN AMERICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
• TABLE 60. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 61. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
• TABLE 62. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 63. EUROPE MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 64. EUROPE MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
• TABLE 65. EUROPE MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 66. EUROPE MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
• TABLE 67. EUROPE MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 68. MIDDLE EAST MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 69. MIDDLE EAST MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
• TABLE 70. MIDDLE EAST MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 71. MIDDLE EAST MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
• TABLE 72. MIDDLE EAST MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 73. AFRICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 74. AFRICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
• TABLE 75. AFRICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 76. AFRICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
• TABLE 77. AFRICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 78. ASIA-PACIFIC MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 79. ASIA-PACIFIC MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
• TABLE 80. ASIA-PACIFIC MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 81. ASIA-PACIFIC MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
• TABLE 82. ASIA-PACIFIC MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 83. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 84. ASEAN MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 85. ASEAN MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
• TABLE 86. ASEAN MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 87. ASEAN MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
• TABLE 88. ASEAN MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 89. GCC MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 90. GCC MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
• TABLE 91. GCC MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 92. GCC MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
• TABLE 93. GCC MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 94. EUROPEAN UNION MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 95. EUROPEAN UNION MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
• TABLE 96. EUROPEAN UNION MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 97. EUROPEAN UNION MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
• TABLE 98. EUROPEAN UNION MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 99. BRICS MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 100. BRICS MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
• TABLE 101. BRICS MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 102. BRICS MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
• TABLE 103. BRICS MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 104. G7 MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 105. G7 MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
• TABLE 106. G7 MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 107. G7 MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
• TABLE 108. G7 MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 109. NATO MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 110. NATO MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
• TABLE 111. NATO MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 112. NATO MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
• TABLE 113. NATO MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 114. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 115. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 116. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
• TABLE 117. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 118. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
• TABLE 119. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 120. CHINA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 121. CHINA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
• TABLE 122. CHINA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 123. CHINA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
• TABLE 124. CHINA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)